Diagnostic and Therapeutic Updates in Leptomeningeal Disease

MA Roy-O'Reilly, T Lanman, A Ruiz, D Rogawski… - Current oncology …, 2023 - Springer
Abstract Purpose of Review Leptomeningeal disease (LMD) is a devastating complication of
advanced metastatic cancer associated with a poor prognosis and limited treatment options …

Leveraging molecular and immune-based therapies in leptomeningeal metastases

JA Wilcox, AA Boire - CNS drugs, 2023 - Springer
Leptomeningeal metastases represent an aggressive stage of cancer with few durable
treatment options. Improved understanding of cancer biology, neoplastic reliance on …

Systemic therapy for melanoma brain and leptomeningeal metastases

WJ Sherman, E Romiti, L Michaelides… - … Treatment Options in …, 2023 - Springer
Current Treatment Options in Oncology edema. Stereotactic radiosurgery offers a benefit
over whole‑brain radiation attributed to the relative radioresistance of melanoma and …

The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management Guidelines

JA Wilcox, R Estrera, A Boire - Current Pain and Headache Reports, 2023 - Springer
Abstract Purpose of Review Headaches are a common, oftentimes debilitating symptom in
patients with leptomeningeal metastases. Recent Findings The third edition of the …

Novel approaches to treatment of leptomeningeal metastases

D Primdahl, A Cohen-Nowak… - Current Opinion in …, 2023 - journals.lww.com
Novel approaches to treatment of leptomeningeal metastases : Current Opinion in Neurology
Novel approaches to treatment of leptomeningeal metastases : Current Opinion in Neurology …

Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors

AB Baskaran, A Bhatia, P Kumthekar, A Boire… - Future …, 2023 - Future Medicine
Aims/purpose: Leptomeningeal metastases (LM) are associated with substantial morbidity
and mortality. Several approaches are used to treat LM, including intrathecally administered …

Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients

S Puri, A Chaudhry, A Bayable, A Ganesh… - Current Oncology …, 2023 - Springer
Abstract Purpose of Review Breast cancer with brain metastasis (BCBM) and
leptomeningeal disease (LMD) are important clinical problems. Traditionally, patients with …

The Evolving Landscape of Leptomeningeal Cancer from Solid Tumors: A Systematic Review of Clinical Trials

L Marenco-Hillembrand, MA Bamimore… - Cancers, 2023 - mdpi.com
Simple Summary Leptomeningeal carcinomatosis is a devastating complication of solid
malignancies and can occur concurrently in patients with brain metastasis. Despite progress …

First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial

M Holdaway, F Ablyazova, S Huda, RS D'Amico… - Journal of Neuro …, 2023 - Springer
Purpose To outline the dose rationale for the first in-human intrathecal delivery of
bevacizumab for LMS of GBM. Methods A 19-year-old female patient presented to Lenox Hill …

Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis

Y Hong, Q Miao, X Zheng, Y Xu, Y Huang… - Journal of Neuro …, 2023 - Springer
Purpose To explore the impact of intrathecal pemetrexed (IP) on the survival of lung
adenocarcinoma (LUAC) patients with leptomeningeal metastasis (LM). Methods We …